Injective Tops Major Blockchains in Revenue-to-FDV Ratio
- —Injective's revenue-to-FDV ratio is 0.95, versus 0.83 for Solana and 0.78 for Arbitrum
- —The ratio is over 8x Ethereum's 0.11 and more than 10x Sui and Avalanche at 0.08
- —Onchain revenue flows into a monthly INJ Community BuyBack that removes tokens permanently
- —Future revenue growth hinges on new tokenization initiatives and product launches
Why it matters: The metric supports a valuation case for INJ, but price gains depend on sustained revenue growth and the buyback's real impact.
Source: Coinpedia